Severity, criticality, and fatality of the SARS-CoV-2 Beta variant
Preprint
- 4 August 2021
- preprint
- research article
- Published by Cold Spring Harbor Laboratory
Abstract
Severity (acute-care hospitalization), criticality (ICU hospitalization), and fatality of SARS-CoV-2 Beta (B.1.351) variant was investigated through case-control studies applied to complete national cohorts of infection, disease, and death cases in Qatar. Compared to Alpha (B.1.1.7) variant, odds of progressing to severe disease were 1.24-fold (95% CI: 1.11-1.39) higher for Beta. Odds of progressing to critical disease were 1.49-fold (95% CI: 1.13-1.97) higher. Odds of COVID-19 death were 1.57-fold (95% CI: 1.03-2.43) higher. Findings highlight risks to healthcare systems, particularly to intensive care facilities and resources, with increased circulation of Beta.Keywords
Other Versions
- Published version: Version , , preprints
This publication has 13 references indexed in Scilit:
- One year of SARS-CoV-2: Genomic characterization of COVID-19 outbreak in QatarPublished by Cold Spring Harbor Laboratory ,2021
- Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021Eurosurveillance, 2021
- Characterizing the Qatar advanced-phase SARS-CoV-2 epidemicScientific Reports, 2021
- Increased mortality among individuals hospitalised with COVID-19 during the second wave in South AfricaPublished by Cold Spring Harbor Laboratory ,2021
- Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort studyBMJ, 2021
- Multiplexed RT-qPCR to screen for SARS-COV-2 B.1.1.7, B.1.351, and P.1 variants of concern v2Published by ZappyLab, Inc. ,2021
- Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021Morbidity and Mortality Weekly Report (MMWR), 2021
- SARS-CoV-2 infection hospitalization, severity, criticality, and fatality ratesPublished by Cold Spring Harbor Laboratory ,2020
- Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care DiagnosticsDiagnostics, 2020
- High-throughput extraction of SARS-CoV-2 RNA from nasopharyngeal swabs using solid-phase reverse immobilization beadsPublished by Cold Spring Harbor Laboratory ,2020